US2013178866A1PendingUtilityA1

Non-Lithotripsic Kidney-Stone Therapy

Assignee: PLUROMED INCPriority: May 2, 2005Filed: Dec 14, 2012Published: Jul 11, 2013
Est. expiryMay 2, 2025(expired)· nominal 20-yr term from priority
A61P 1/18A61P 13/04A61P 13/12A61P 1/16A61K 9/0019A61B 17/32056A61K 49/0002A61B 2017/00849A61K 47/36A61L 24/001A61B 2017/00818A61B 2018/00511A61L 2400/06A61B 2017/22082A61B 2018/005A61K 47/10A61B 2017/00853A61K 9/0068A61L 24/046C08L 71/02A61B 17/22A61B 2017/22037
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

One aspect of the present invention relates to a method of using peristalsis to force a polymer plug through a mammalian lumen, thereby removing any calculi and/or calculi fragments present in the lumen. In one embodiment, the method is used as an alternative to conventional lithotripsy. In another embodiment, the method is used in conjunction with lithotripsy, thereby removing the small calculi fragments that result from such procedures.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method of treating lithiasis, comprising the steps of:
 injecting into a lumen of a mammal at a first distance upstream from a calculi a first composition comprising between 12 and 25 weight percent of an inverse thermosensitive polymer selected from a block copolymer, random copolymer, graft polymer, or branched copolymer, wherein said first composition does not initially contact said calculi; thereby forming a polymer plug; and removing the calculi from the lumen by movement of the polymer plug by peristalsis to traverse said lumen, thereby forcing said calculi from said lumen.   
     
     
         2 . The method of  claim 1 , further comprising injecting into said lumen a second composition at a second distance upstream from said calculi wherein said second composition does not contact said calculi. 
     
     
         3 . The method of  claim 1 , wherein said first distance is between about 1 cm and about 5 cm upstream of said calculi. 
     
     
         4 . The method of  claim 2 , wherein the distance between said first distance and said second distance is less than about 3 mm. 
     
     
         5 . The method of  claim 1 , wherein said first composition is injected into said lumen through a percutaneous access device. 
     
     
         6 . The method of  claim 1 , wherein said lumen is or is a portion of a kidney, gall bladder, ureter, urinary bladder, pancreas, salivary gland, small intestine, or large intestine. 
     
     
         7 . The method of  claim 1 , wherein said lumen is or is a portion of a ureter or kidney. 
     
     
         8 . The method of  claim 1 , wherein said calculi is a kidney stone, pancreatic stone, salivary stone, or biliary stone. 
     
     
         9 . The method of  claim 1 , wherein said calculi is a kidney stone. 
     
     
         10 . A method of treating lithiasis, comprising the steps of:
 injecting into a lumen of a human at a first distance upstream from a calculi a first composition comprising an inverse thermosensitive polymer, wherein said first composition does not initially contact said calculi; thereby forming a polymer plug; injecting into said lumen a second composition at a second distance upstream from said calculi wherein said second composition does not contact said calculi; and removing the calculi from the lumen by movement of the polymer plug by peristalsis to traverse said lumen, thereby forcing said calculi from said lumen.   
     
     
         11 . The method of  claim 10 , wherein said second composition comprises a contrast-enhancing agent. 
     
     
         12 . The method of  claim 10 , wherein said contrast-enhancing agent is selected from the group consisting of radiopaque materials, paramagnetic materials, heavy atoms, transition metals, lanthanides, actinides, dyes, and radionuclide-containing materials. 
     
     
         13 . The method of  claim 10 , wherein said inverse thermosensitive polymer is an optionally purified poloxamer or poloxamine. 
     
     
         14 . The method of  claim 10 , wherein said inverse thermosensitive polymer is optionally purified and selected from the group consisting of poloxamine 1107, poloxamine 1307, poloxamer 338 and poloxamer 407. 
     
     
         15 . The method of  claim 10 , wherein said inverse thermosensitive polymer is an optionally purified poloxamer 407. 
     
     
         16 . The method of  claim 10 , wherein said first composition has a transition temperature of between about 10° C. and 40° C. 
     
     
         17 . The method of  claim 10 , wherein said lumen is or is a portion of a kidney, gall bladder, ureter, urinary bladder, pancreas, salivary gland, small intestine or large intestine. 
     
     
         18 . The method of  claim 10 , wherein said lumen is or is a portion of a ureter or kidney. 
     
     
         19 . The method of  claim 10 , wherein said calculi is a kidney stone, pancreatic stone, salivary stone, or biliary stone. 
     
     
         20 . The method of  claim 1 , wherein the polymer plug is non-tissue adhesive. 
     
     
         21 . The method of  claim 2 , wherein the second composition comprises a cross-linker solution.

Join the waitlist — get patent alerts

Track US2013178866A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.